EVALUATION OF CYTOKINE TOXICITY INDUCED BY VACCINIA VIRUS-MEDIATED IL-2 AND IL-12 ANTITUMOUR IMMUNOTHERAPY

This publication has 27 references indexed in Scilit:

• Evaluation of combined vaccinia virus–mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model
  Cancer Gene Therapy, 2000
• Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
  Gene Therapy, 1999
• Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors
  Gene Therapy, 1998
• Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study
  Gene Therapy, 1998
• In VivoTherapy of Hepatocellular Carcinoma with a Tumor-Specific Adenoviral Vector Expressing Interleukin-2
  Human Gene Therapy, 1997
• Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12
  Human Gene Therapy, 1996
• In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1beta
  Surgery, 1995
• Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.
  The Journal of Experimental Medicine, 1990
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Tumor necrosis factor and the acute metabolic response to tissue injury in man.
  Journal of Clinical Investigation, 1988